Medicure Inc. (OTCMKTS:MCUJF – Get Free Report)’s share price crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.60 and traded as low as $0.46. Medicure shares last traded at $0.48, with a volume of 5,100 shares changing hands.
Medicure Price Performance
The stock’s 50-day moving average is $0.51 and its 200 day moving average is $0.60. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.64 and a current ratio of 2.03. The stock has a market capitalization of $5.05 million, a PE ratio of -3.45 and a beta of 0.87.
About Medicure
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Read More
- Five stocks we like better than Medicure
- What is a penny stock? A comprehensive guide
- Newsmax’s IPO Whiplash: Meme Stock Hype or Growth Potential?
- NYSE Stocks Give Investors a Variety of Quality Options
- Disney 2025 Shareholders: Major Updates for Investors
- The Risks of Owning Bonds
- Advance Auto Parts Stock: A Classic Rebound Play in the Making
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
